Key result
Mammary adipocyte diameter correlates positively with BMI, crown-like structure density, and aromatase expression.
Why the study?
Mammary adipose tissue functions as an active endocrine organ potentially influencing breast carcinogenesis through metabolic and inflammatory mechanisms, but associations between adipocyte size, adipose tissue dysfunction, and breast cancer required systematic synthesis.
Is mammary adipocyte size associated with systemic adiposity, local breast inflammation, and aromatase expression?
Meta-Analysis
Is mammary adipocyte size associated with systemic adiposity, local breast inflammation, and aromatase expression?
Effect estimate: r = 0.44 (95% CI 0.29-0.56)
Mammary adipocyte size correlates with systemic adiposity, local inflammation, and aromatase expression, supporting its potential role in obesity-related breast carcinogenesis.
Associates mammary adipocyte hypertrophy with obesity-driven inflammation; extends mechanistic links in breast cancer but remains hypothesis-generating.
Background/Objectives: Mammary adipose tissue functions as an active endocrine organ, potentially influencing breast carcinogenesis through metabolic and inflammatory mechanisms. This systematic review synthesized evidence on associations between mammary adipocyte size, obesity-related adipose tissue dysfunction, and breast cancer. Methods: A comprehensive literature search was conducted across MEDLINE, EMBASE, CENTRAL, CINAHL and Web of Science (January 2010–September 2025) for observational studies measuring mammary adipocyte size in human breast tissue. Two reviewers independently conducted screening following the Cochrane Review’s rigorous methodology, and bias assessment using the ROBINS-E (Risk Of Bias In Non-randomized Studies of Exposure) tool. Random-effects meta-analyses were performed for quantifiable outcomes, with heterogeneity assessed using the I2 statistic. Results: Twenty-one studies were included in the systematic review. Meta-analyses indicated that mammary adipocyte diameter was positively correlated with body mass index (8 studies; n = 720; correlation coefficient (r) = 0.44, 95% CI: 0.29–0.56), crown-like structure (CLS) density (5 studies; n = 383; r = 0.45, 95% confidence interval (CI): 0.36–0.54), aromatase expression (3 studies; n = 333; r = 0.36, 95% CI: 0.05–0.61), and three studies compared adipocyte diameter between CLS-positive and CLS-negative tissue (n = 297; mean difference = 9.69 μm, 95% CI: 4.94–14.44). Conclusions: This review summarizes moderate positive correlations of mammary adipocyte size with systemic adiposity, local breast inflammation, and aromatase expression, supporting a potential role for mammary adipose tissue in obesity-related metabolic dysfunction. Future prospective studies with standardized measurement protocols and improved control for confounding variables are needed to strengthen causal inference and clinical applications.
No takes yet. Share an insight, caveat, or question.
Badre et al. (2026) conducted a meta-analysis in Breast cancer and obesity-related breast adipose tissue dysfunction. Mammary adipocyte size was evaluated on Correlation between mammary adipocyte diameter and body mass index (r = 0.44, 95% CI 0.29-0.56). Mammary adipocyte diameter was positively correlated with body mass index (r = 0.44; 95% CI 0.29-0.56), crown-like structure density, and aromatase expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: